Wednesday, May 22, 2019

Iovance Biotherapeutics Announces Breakthrough Therapy Designation for LN-145 for Treatment of Advanced Cervical Cancer Patients Who Have Progressed on or After Chemotherapy - Associated Press https://t.co/EeONAqcfHn


from Twitter https://twitter.com/IDROOhio

May 22, 2019 at 12:27PM

No comments:

Post a Comment